Oral Azacitidine Wins FDA Approval for AML

(MedPage Today) -- WASHINGTON--The FDA approved an oral formulation of azacitidine (Onureg) for continued treatment of adults with acute myeloid leukemia (AML) in first remission but unable to continue intensive therapy.
Supporting data for...